Journal of International Obstetrics and Gynecology ›› 2015, Vol. 42 ›› Issue (5): 533-535.

• 论著 • Previous Articles     Next Articles

The Study of the CD28/CTLA-4 Disturbance in Early-onset Severe Preeclampsia Prior to Delivery and after Parturition

ZHANG Na-na,LYU Ying-pu,YANG Shi-fang,CHEN Yan-jun,ZHANG Wen-zhen,LI Cong-wei   

  1. Department of Obstetrics,Third Hospital of Shijiazhuang,Shijiazhuang 050011,China(ZHANG Na-na,YANG Shi-fang,CHEN Yan-jun,LI Cong-wei);Department of Obstetrics,First Hospital of Shijiazhuang,Shijiazhuang 050011,China(LYU Ying-pu);Department of Obstetrics,Second Hospital,Hebei Medical University,Shijiazhuang 050000,China(ZHANG Wen-zhen)
  • Received:1900-01-01 Revised:1900-01-01 Published:2015-10-15 Online:2015-10-15
  • Contact: ZHANG Na-na

Abstract: Objective:To study the alteration of the leukocyte differentiation antigens 28/cytotoxic T lymphocyte antigen 4 (CD28/CTLA-4) in maternal blood lymphocyte from patients with early-onset severe preeclampsia to investigate the function of CD28/CTLA-4 in the pathogenesis of early-onset severe preeclampsia. Methods:Peripheral blood from 30 patients with early-onset preeclampsia (PE) [prior to delivery (PTD) and after parturition (AP)]. It applies flow cytometry to detect expression of CD28/CTLA-4 of peripheral lymphocytes in CD4+T and CD8+T cells. At the same time, to determine blood pressure and the functions of liver and kidney. Results:The CD3+CD4+CTLA-4+, CD3+CD8+CTLA-4+ cells in early-onset severe preeclampsia before delivery above after childbirth, CD3+CD4+CD28+/CD3+CD4+CTLA-4+, CD3+CD8+CD28+/CD3+CD8+ CTLA-4+ below after childbirth, was statistically significant (P<0.05). There isn′t correlation between the CD3+CD4+CD28+/CD3+CD4+CTLA-4+ and CD3+CD8+CD28+/CD3+CD8+CTLA-4+ (r=-0.037, P=0.844). Conclusions:After parturition, the station about the decrease of CTLA-4 and the increase of CD28/CTLA-4 might be relation to early-onset preeclampsia.

Key words: Pre-eclampsia, Antigens, CD28, T-lymphocyte subsets, Th1 cells, Th2 cells, Cytotoxic T-lymphocyte-associated antigen 4